← Open Payments lookup

ASHLEIGH REIMANN: Open Payments

NPI 1154738771 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,377 in 68 payments from 20 companies in 2025. Trend: 2023 $1,497 · 2024 $1,485 · 2025 $1,377

Food & beverage: $1,377
CompanyPaymentsAmount
Amgen Inc.15$225
GlaxoSmithKline, LLC.9$199
Mallinckrodt Hospital Products Inc.8$181
Merck Sharp & Dohme LLC7$139
AstraZeneca Pharmaceuticals LP5$101
Vifor Pharma, Inc.3$68
Boehringer Ingelheim Pharmaceuticals, Inc.3$66
Regeneron Healthcare Solutions, Inc.2$49
Takeda Pharmaceuticals U.S.A., Inc.2$48
Axsome Therapeutics, Inc.2$46

Products named: TEZSPIRE, ACTHAR, ZERBAXA, TRELEGY ELLIPTA, DUPIXENT, Zemaira, OFEV, NUCALA.

Industry payments across AL — which companies pay providers there.